Crystalline anhydrous aztreonam

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

540355, C07D205085, A61K 31395

Patent

active

049468383

ABSTRACT:
The crystalline anhydrous form of [3S-[3.alpha.(Z), 4.beta.]]-3-[[(2-amino-4-thiazolyl) [(1-carboxy-1-methylethoxy)imino]acetyl]amino]-4-methyl-2-oxo-1-azetidines ulfonic acid is prepared.

REFERENCES:
patent: Re28744 (1986-03-01), Long et al.
patent: 2985648 (1961-05-01), Doyle
patent: 3157640 (1964-11-01), Johnson
patent: 3192198 (1965-06-01), Nayler
patent: 3485819 (1969-12-01), Weisenborn
patent: 3507861 (1970-04-01), Morin
patent: 3655656 (1972-04-01), Van Heyningen
patent: 3819620 (1974-06-01), Dursch
patent: 3905960 (1975-09-01), Clark
patent: 3932386 (1976-01-01), Nescio
patent: 4006138 (1977-02-01), Yang
patent: 4529698 (1985-07-01), Sykes
Monkhouse, Drug Development and Industrial Pharmacy, 10, 1373-1392, 1393 (1984).
Physicians Desk Reference, 1986, pp. 302, 305.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Crystalline anhydrous aztreonam does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Crystalline anhydrous aztreonam, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline anhydrous aztreonam will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-960763

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.